IntrinsicIntrinsic
← Scroll for more →

Financial Statements — TRNR

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Cash & Equivalents0.964.740.510.850.582.210.142.270.160.000.000.031.401.05
Accounts Receivable3.202.512.612.381.761.761.430.520.260.180.000.010.010.01
Inventory8.218.077.338.215.586.066.697.978.768.975.524.564.784.59
Total Current Assets10.2114.0514.7017.3714.9611.448.2210.248.278.885.365.728.557.71
Property, Plant & Equipment0.630.440.380.330.070.080.120.160.240.390.440.580.811.05
Goodwill20.6420.6415.5515.1413.2213.2213.2213.5213.5513.23--------
Intangible Assets15.9517.107.868.125.285.656.117.187.758.492.252.873.213.35
Total Non-current Assets*46.3146.6032.1468.0771.2826.3725.9527.5129.5030.6911.4512.5513.1718.05
Total Assets56.5260.6446.8485.4486.2437.8234.1737.7537.7739.5616.8018.2721.7225.76
Accounts Payable8.199.368.988.944.677.7011.1712.8813.6013.2510.568.928.338.31
Short-term Debt------12.429.98------------------
Total Current Liabilities49.1436.4831.2930.8122.2121.2626.8826.5535.6038.5321.5318.3016.4324.13
Long-term Debt------46.4355.1310.9011.3214.08------------
Total Non-current Liabilities*4.0316.196.8637.1747.762.800.175.411.751.290.820.240.270.59
Total Liabilities53.1752.6738.1567.9869.9724.0627.0631.9637.3539.8222.3518.5516.7024.72
Retained Earnings(245.39)(238.28)(227.54)(217.19)(211.96)(209.39)(202.59)(196.62)(188.94)(178.30)(166.91)(155.51)(145.10)(131.50)
Total Stockholder Equity3.345.676.3914.8616.2713.767.125.790.41(2.94)(5.55)(0.27)5.011.04
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Total Revenue6.655.144.144.821.221.362.382.010.620.360.180.310.320.16
Cost of Revenue3.433.533.553.991.411.662.792.301.501.561.801.431.451.81
Gross Profit3.221.610.590.83(0.19)(0.30)(0.41)(0.29)(0.88)(1.20)(1.62)(1.12)(1.14)(1.65)
Research & Development0.420.440.460.400.781.270.282.212.472.022.252.362.333.11
Selling, General & Admin3.994.130.465.994.644.492.905.064.425.967.236.317.8815.85
Total Operating Expenses6.595.602.286.865.636.013.707.477.008.249.648.9510.8019.56
Operating Income(3.37)(3.99)(1.69)(6.03)(5.82)(6.31)(4.11)(7.75)(7.88)(9.44)(11.26)(10.07)(11.94)(21.21)
Pretax Income--(10.74)(9.95)(5.23)(2.18)(6.60)(5.76)(7.14)(10.64)(11.39)(11.40)(10.41)(13.60)(15.96)
Tax Provision--0.000.000.000.000.000.000.000.000.000.000.000.000.00
Net Income(7.10)(10.74)(9.95)(5.23)(2.18)(6.60)(5.76)(7.14)(10.64)(11.39)(11.40)(10.41)(16.87)(15.96)
Basic EPS(17.37)(71.68)(1,153.53)(21.77)(14.91)(12.18)(1,005.20)(10.71)(122.36)(4.69)(2.17)(5.11)(7.14)(14.63)
Diluted EPS(17.37)(71.68)(1,153.53)(21.77)(14.91)(12.18)(1,005.20)(10.71)(122.36)(4.69)(2.17)(5.11)(7.14)(14.63)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Operating Cash Flow(3.05)(2.59)(2.25)(2.42)(2.20)(3.54)(5.90)(3.75)(2.20)(2.96)(1.87)(2.36)(6.46)(4.74)
Capital Expenditures0.240.10----------------0.000.000.000.00
Free Cash Flow*(3.29)(2.68)----------------(1.87)(2.36)(6.46)(4.74)
Investing Cash Flow(0.74)4.15(0.25)(2.52)(48.78)(2.19)(0.27)0.000.30(1.71)(0.28)(0.28)(0.45)(0.42)
Financing Cash Flow(0.01)2.712.372.9451.537.773.396.272.064.622.450.977.516.18
← Scroll for more columns →

* Derived from reported values